Synthetic Biotechnology to Study and Engineer Ribosomal Bottromycin Biosynthesis
- 1 October 2012
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 19 (10), 1278-1287
- https://doi.org/10.1016/j.chembiol.2012.08.013
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- YcaO domains use ATP to activate amide backbones during peptide cyclodehydrationsNature Chemical Biology, 2012
- Radical-Mediated Enzymatic Methylation: A Tale of Two SAMSAccounts of Chemical Research, 2011
- Antibiotics for Emerging PathogensScience, 2009
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?Science, 2009
- How Nature Morphs Peptide Scaffolds into AntibioticsChemBioChem, 2008
- Morphing peptide backbones into heterocyclesProceedings of the National Academy of Sciences of the United States of America, 2008
- Discovery of a widely distributed toxin biosynthetic gene clusterProceedings of the National Academy of Sciences of the United States of America, 2008
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002
- Bottromycin. II. Preliminary Degradation StudiesJournal of the American Chemical Society, 1957
- Bottromycin. I. A New Sulfur-containing AntibioticJournal of the American Chemical Society, 1957